Skip to content
Recall Observatory FDA recall evidence

Drug product

AvKARE Valsartan and Hydrochlorothiazide 320 mg/25 mg tablets 90-count bottle, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478, NDC 42291-888-90

D-1177-2018

July 18, 2018

Class II

Product summary

Firm
Avkare Incorporated
Event
Event 80940
Status
Terminated
Classification
Class II
Quantity
19623 bottles
Official record key
drug-enforcement:D-1177-2018

Official wording

Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Code information: Lots: 17308 Exp. 09/2018; 18158 Exp. 09/2018; 18539 Exp. 01/2019; 19021 Exp. 01/2019; 19225 Exp. 01/2019; 20033 Exp. 06/2019; 20290 Exp. 06/2019; 20565 Exp. 06/2019; 21369 Exp. 10/2019

Distribution pattern: Nationwide

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations